Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death

Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death

  • April 28, 2026

Erasca has backed up bullish claims about its pan-RAS drug having a best-in-class profile, publishing phase 1 data that an analyst said reveal a “home run profile.”

Leave A Comment

Fields (*) Mark are Required